Evidence map›Paper›PMID 20307509›Full record

ArticleBrain research2010

A helper virus-free HSV-1 vector containing the vesicular glutamate transporter-1 promoter supports expression preferentially in VGLUT1-containing glutamatergic neurons.

Guo-rong Zhang, Alfred I Geller

Abstract read
In one paragraph

Article in Brain research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Guo-rong ZhangDepartment of Neurology, West Roxbury VA Hospital/Harvard Medical School, W. Roxbury, MA 02132, USA.
Alfred I Geller
Harvard University · US

Funding

Promoters for Long-term Expression from HSV-1 VectorsR01NS045855 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GELLER, ALFRED I. · 2003 to 2011
$2.0M
Targeted Gene Transfer, to Specific Types of Neurons, with HSV-1 VectorsR01NS057558 · NINDS · HARVARD MEDICAL SCHOOL · PI GELLER, ALFRED I. · 2007 to 2011
$1.3M
Correcting Cognitive Deficits by Gene TherapyK01AG025894 · NIA · HARVARD MEDICAL SCHOOL · PI ZHANG, GUORONG · 2006 to 2010
$615k
NIA NIH HHS AG025894NIA NIH HHS K01 AG025894NINDS NIH HHS NS045855NINDS NIH HHS NS057558NINDS NIH HHS R01 NS045855NINDS NIH HHS R01 NS057558
6 · The paper itself

Abstract

Multiple potential uses of direct gene transfer into neurons require restricting expression to specific classes of glutamatergic neurons. Thus, it is desirable to develop vectors containing glutamatergic class-specific promoters. The three vesicular glutamate transporters (VGLUTs) are expressed in distinct populations of neurons, and VGLUT1 is the predominant VGLUT in the neocortex, hippocampus, and cerebellar cortex. We previously reported a plasmid (amplicon) Herpes Simplex Virus (HSV-1) vector that placed the Lac Z gene under the regulation of the VGLUT1 promoter (pVGLUT1lac). Using helper virus-free vector stocks, we showed that this vector supported approximately 90% glutamatergic neuron-specific expression in postrhinal (POR) cortex, in rats sacrificed at either 4 days or 2 months after gene transfer. We now show that pVGLUT1lac supports expression preferentially in VGLUT1-containing glutamatergic neurons. pVGLUT1lac vector stock was injected into either POR cortex, which contains primarily VGLUT1-containing glutamatergic neurons, or into the ventral medial hypothalamus (VMH), which contains predominantly VGLUT2-containing glutamatergic neurons. Rats were sacrificed at 4 days after gene transfer, and the types of cells expressing ss-galactosidase were determined by immunofluorescent costaining. Cell counts showed that pVGLUT1lac supported expression in approximately 10-fold more cells in POR cortex than in the VMH, whereas a control vector supported expression in similar numbers of cells in these two areas. Further, in POR cortex, pVGLUT1lac supported expression predominately in VGLUT1-containing neurons, and, in the VMH, pVGLUT1lac showed an approximately 10-fold preference for the rare VGLUT1-containing neurons. VGLUT1-specific expression may benefit specific experiments on learning or specific gene therapy approaches, particularly in the neocortex.

Indexed as

Gene Transfer TechniquesAnimalsBrainFluorescent Antibody TechniqueGene ExpressionGenetic VectorsGlutamic AcidHelper VirusesHerpesvirus 1, HumanImage Processing, Computer-AssistedImmunohistochemistryMaleNeuronsPromoter Regions, GeneticRatsRats, Sprague-DawleyGlutamic AcidSlc17a7 protein, ratVesicular Glutamate Transport Protein 1

Identifiers

PMID20307509
PMCPMC2862811
OpenAlexW2073258615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.